When can we stop using oral poliovirus vaccine?

被引：6

作者：

Hull, HF

Minor, PD

机构：

[1] Minnesota Dept Hlth, Infect Dis Epidemiol Prevent & Control Div, St Paul, MN 55164 USA

[2] Natl Inst Biol Stand & Controls, Div Virol, Potters Bar EN6 3QG, Herts, England

来源：

JOURNAL OF INFECTIOUS DISEASES | 2005年 / 192卷 / 12期

关键词：

D O I：

10.1086/498171

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：2033 / 2035

页数：3

共 9 条

[1]

Fine PEM, 2004, B WORLD HEALTH ORGAN, V82, P47

[2]

Greenwood BM, 1997, J INFECT DIS, V175, pS215

[3]

Halsey NA, 2004, B WORLD HEALTH ORGAN, V82, P3

[4] Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire [J].

Hennessey, KA ;

Lago, H ;

Diomande, F ;

Akoua-Koffi, C ;

Caceres, VM ;

Pallansch, MA ;

Kew, OM ;

Nolan, M ;

Zuber, PLF .

JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (12) :2124-2128

[5] Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains [J].

Laassri, M ;

Lottenbach, K ;

Belshe, R ;

Wolff, M ;

Rennels, M ;

Plotkin, S ;

Chumakov, K .

JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (12) :2092-2098

[6] Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man [J].

MacLennan, C ;

Dunn, G ;

Huissoon, AP ;

Kumararatne, DS ;

Martin, J ;

O'Leary, P ;

Thompson, RA ;

Osman, H ;

Wood, P ;

Minor, P ;

Wood, DJ ;

Pillay, D .

LANCET, 2004, 363 (9420) :1509-1513

[7]

Sutter RW, 2004, B WORLD HEALTH ORGAN, V82, P31

[8]

World Health Organisation, 2005, CESS ROUT OR POL VAC

[9]

Yoneyama T, 2001, Dev Biol (Basel), V105, P93

← 1 →